Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites
- 31 July 2010
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 121 (1-2), 438-441
- https://doi.org/10.1016/j.jsbmb.2010.03.052
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Genetic Variability in the MTHFR Gene and Colorectal Cancer Risk Using the Colorectal Cancer Family RegistryCancer Epidemiology, Biomarkers & Prevention, 2010
- Vitamin D-related genes, serum vitamin D concentrations and prostate cancer riskCarcinogenesis: Integrative Cancer Research, 2009
- Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, ChinaCarcinogenesis: Integrative Cancer Research, 2008
- So Many Correlated Tests, So Little Time! Rapid Adjustment of P Values for Multiple Correlated TestsAmerican Journal of Human Genetics, 2007
- Assessment of Circulating 25(OH)D and 1,25(OH)2 D: Emergence as Clinically Important Diagnostic ToolsNutrition Reviews, 2007
- Synergistic effects of RXR and PPAR ligands to inhibit growth in human colon cancer cells phosphorylated RXR is a critical target for colon cancer managementGut, 2007
- Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25‐hydroxyvitamin D and 1,25‐dihydroxyvitamin D, and prostate cancer riskThe Prostate, 2007
- Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrenceThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- The vitamin D questions: How much do you need and how should you get it?Journal of the American Academy of Dermatology, 2006
- Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian populationEuropean Journal of Cancer, 2005